A bladder treatment for selected cancer unresponsive to BCG when immediate surgery is unsuitable.
Profile scope: Valrubicin intravesical. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Urinary discomfort or frequency, abdominal discomfort, fatigue, or stomach upset may occur.
Serious risks and warning signs
Persistent red urine or pain beyond the expected early period, or blood in urine, requires immediate advice. Limited response and the danger of delaying necessary surgery are important treatment risks.
A question for your healthcare team
What is the response-assessment deadline, and when would delaying surgery become unsafe?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.